Your browser doesn't support javascript.
loading
Definition of early age at onset in bipolar disorder according to distinctive neurodevelopmental pathways: insights from the FACE-BD study.
Corponi, Filippo; Lefrere, Antoine; Leboyer, Marion; Bellivier, Frank; Godin, Ophelia; Loftus, Josephine; Courtet, Philippe; Dubertret, Caroline; Haffen, Emmanuel; Llorca, Pierre Michel; Roux, Paul; Polosan, Mircea; Schwan, Raymund; Samalin, Ludovic; Olié, Emilie; Etain, Bruno; Seriès, Peggy; Belzeaux, Raoul.
Afiliação
  • Corponi F; School of Informatics, University of Edinburgh, Edinburgh, UK.
  • Lefrere A; Assistance Publique Hôpitaux de Marseille, Pôle de Psychiatrie, Marseille, France.
  • Leboyer M; Fondation FondaMental, Créteil, France.
  • Bellivier F; Institut de neurosciences de la Timone UMR 7289, Aix-Marseille Université & CNRS, Marseille, France.
  • Godin O; Fondation FondaMental, Créteil, France.
  • Loftus J; Assistance publique des hôpitaux de Paris, Hôpitaux Universitaires Henri Mondor, Département Médico-Universitaire de Psychiatrie et d'Addictologie (DMU IMPACT), Fédération Hospitalo-Universitaire de Médecine de Précision en Psychiatrie (FHU ADAPT), Créteil, France.
  • Courtet P; Translational NeuroPsychiatry Laboratory, Université Paris Est Créteil (UPEC), INSERM U955, IMRB, Paris, France.
  • Dubertret C; Fondation FondaMental, Créteil, France.
  • Haffen E; Université de Paris, INSERM UMR-S 1144, Optimisation Thérapeutique en Neuropsychopharmacologie OTeN, Paris, France.
  • Llorca PM; Assistance publique des Hôpitaux de Paris, Groupe Hospitalo-universitaire AP-HP Nord, Hôpital Lariboisière, Département de Psychiatrie et de Médecine Addictologique, Paris, France.
  • Roux P; Fondation FondaMental, Créteil, France.
  • Polosan M; Translational NeuroPsychiatry Laboratory, Université Paris Est Créteil (UPEC), INSERM U955, IMRB, Paris, France.
  • Schwan R; Fondation FondaMental, Créteil, France.
  • Samalin L; Pôle de Psychiatrie, Centre Hospitalier Princesse Grace, France, Monaco.
  • Olié E; Fondation FondaMental, Créteil, France.
  • Etain B; IGF, Univ. Montpellier France, CNRS, INSERM, Montpellier, France.
  • Seriès P; Fondation FondaMental, Créteil, France.
  • Belzeaux R; Assistance publique des hôpitaux de Paris, Groupe Hospitalo-universitaire AP-HP Nord, DMU ESPRIT, Service de Psychiatrie et Addictologie, Hôpital Louis Mourier, Colombes, France.
Psychol Med ; : 1-9, 2023 Feb 28.
Article em En | MEDLINE | ID: mdl-36852971
ABSTRACT

BACKGROUND:

Converging evidence suggests that a subgroup of bipolar disorder (BD) with an early age at onset (AAO) may develop from aberrant neurodevelopment. However, the definition of early AAO remains unprecise. We thus tested which age cut-off for early AAO best corresponds to distinguishable neurodevelopmental pathways.

METHODS:

We analyzed data from the FondaMental Advanced Center of Expertise-Bipolar Disorder cohort, a naturalistic sample of 4421 patients. First, a supervised learning framework was applied in binary classification experiments using neurodevelopmental history to predict early AAO, defined either with Gaussian mixture models (GMM) clustering or with each of the different cut-offs in the range 14 to 25 years. Second, an unsupervised learning approach was used to find clusters based on neurodevelopmental factors and to examine the overlap between such data-driven groups and definitions of early AAO used for supervised learning.

RESULTS:

A young cut-off, i.e. 14 up to 16 years, induced higher separability [mean nested cross-validation test AUROC = 0.7327 (± 0.0169) for ⩽16 years]. Predictive performance deteriorated increasing the cut-off or setting early AAO with GMM. Similarly, defining early AAO below 17 years was associated with a higher degree of overlap with data-driven clusters (Normalized Mutual Information = 0.41 for ⩽17 years) relatively to other definitions.

CONCLUSIONS:

Early AAO best captures distinctive neurodevelopmental patterns when defined as ⩽17 years. GMM-based definition of early AAO falls short of mapping to highly distinguishable neurodevelopmental pathways. These results should be used to improve patients' stratification in future studies of BD pathophysiology and biomarkers.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article